Axsome Therapeutics, Inc.

New York

506 Total Employees

Year Founded: 2012

View Website

What's It Like to Work at Axsome Therapeutics, Inc.?

Updated on September 05, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Axsome Therapeutics, Inc. and has not been reviewed or approved by Axsome Therapeutics, Inc..

What's it like to work at Axsome Therapeutics, Inc.?

Strengths in mission impact, competitive rewards, and rapid advancement potential are accompanied by a fast pace, uneven management practices, and ongoing change. Together, these dynamics suggest a workplace well-suited to growth-minded individuals comfortable with ambiguity and intensity, while those prioritizing stability and consistent manager experience may find the environment challenging.

Key Insight for Candidates

Defining tradeoff: aggressive, launch‑mode scaling with frequently changing metrics versus strong equity and growth upside. Axsome’s rapid commercial buildout creates impact and earning potential, but also a high-pressure, micromanaged environment where processes lag growth. Candidates comfortable with constant change may thrive; those seeking steady structures may struggle.

Evidence in Action

Launch-Driven Priority Shifts — Auvelity’s June 2026 Alzheimer’s agitation launch, Q2 2026 net product revenue of $218.4M, and the SUMMIT Phase 3 for AXS‑05 normalize rapid reprioritization. Employees see frequent pivots, compressed timelines, and intensity around milestones, shaping a high-change daily rhythm.
Evolving Field KPIs — Auvelity sales‑force expansion toward ~600 reps and recurring employee feedback on changing metrics reinforce a performance‑first cadence. Field teams face shifting goals and close oversight, affecting autonomy, workload, and how predictable the job feels.

Positive Themes About Axsome Therapeutics, Inc.

Mission & Purpose: Work centers on CNS therapies with marketed products (Auvelity, Sunosi) and visible late-stage programs, creating clear line-of-sight to patient impact. Recent label expansion and new clinical starts indicate momentum that can be energizing for purpose-driven teams.
Compensation: Pay is characterized as competitive with bonuses and significant equity, alongside an ESPP and 401(k) match. Field and medical roles in particular are described as offering strong total compensation.
Career Growth: Rapid headcount expansion and commercial build-outs create stretch roles and new-build opportunities. Scaling through 2025–2026 suggests accelerated scope for those who like building.

Considerations About Axsome Therapeutics, Inc.

Workload & Burnout: A high-velocity, launch-mode environment with evolving priorities and aggressive targets can produce long hours and sustained pressure. Commercial expansion and late-stage milestones increase execution intensity.
Weak Management: Micromanagement and frequently changing metrics in parts of the organization point to uneven manager effectiveness. Shifting targets and directive oversight in some areas suggest inconsistent coaching and clarity at the team level.
Change Fatigue: Rapid scaling, label expansions, and pivotal readouts can reset priorities and processes quickly. Such pace and ambiguity are typical of fast growers and may strain those seeking steadier structures.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.